Oguzhan Atay is the Co-Founder and CEO of BillionToOne, a precision diagnostics company advancing molecular testing through its proprietary molecular counting platform. The company is transforming disease detection in areas like non-invasive prenatal screening and liquid biopsy by accurately quantifying biological molecules.
Oguzhan holds a Ph.D. in Systems Biology from Stanford, where he applied machine learning and mathematical modeling to cellular biology. He also earned a degree in Molecular Biology from Princeton, with minors in Computer Science, Physics, and Applied Mathematics.
.png)
.png)